Abstract
Molecular imaging of radiotracer distribution by PET or SPECT studies permits the measurement of the time course of uptake and clearance of specific tracers from different organs, and tissues. Quantitative measurement of the local radiotracer activity is essential to assess the local physiological function quantitatively. The standardized uptake value (SUV) is a unit-less number that normalizes the lesion uptake to the injected dose per unit of body weight. The radiotracer kinetic physiologic modeling of dynamic imaging data provides the link between activity levels measured in a specific region of interest (ROI) in the functional scan and the physiologic parameters associated with the particular function being studied. Two- and three-compartment models can be used to describe radiotracer kinetics in vivo. Based on the equations of ligand-receptor interactions, quantitative parameters such as binding potential and affinity can be estimated. Graphical analysis techniques (such as Patlak and Logan plot) are simple methods for the analysis of data from radiotracer PET and SPECT imaging studies. This chapter provides a broad overview of pharmacokinetic modeling techniques, and practical applications of determining the quantitative parameters from dynamic molecular imaging data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acton PD, Zhuang H, Alavi A. Quantification in PET. Radiol Clin North Am. 2004;42:1055–62.
Hofheinz F, Apostolova I, Oehme L. Test–retest variability in lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials. J Nucl Med. 2017;58(11):1770–5.
Huang S. Anatomy of SUV: standardized uptake value. Nucl Med Biol. 2000;27:643–6.
Kinahan PE, Fletcher JW. PET/CT standardized uptake values (SUVs) in clinical practice and assessing response to therapy. Semin Ultrasound CT MR. 2010;31(6):496–505.
Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847–50.
Michaelis L, Menten ML. Die Kinetik der Invertinwirkung. Biochem Z. 1913;49:1333.
Farde L, Eriksson L, Blomquist G, et al. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab. 1989;9:696–708.
Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med. 2001;42(5):755–63.
Laruelle M, Slifstein M, Huang Y. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. Mol Imaging Biol. 2003;5:363–75.
Lassen NA, Ingvar DH, Skinhoj G. Brain function and blood flow. Sci Am. 1978;239:62–71.
Raichle ME, Martin WR, et al. Brain blood flow measured with intravenous [15O]H2O. II. Implementation and validation. J Nucl Med. 1983;24:790–8.
Crone C. Permeability of capillaries in various organs as determined by the indicator diffusion method. Acta Physiol Scand. 1964;58:292–305.
Phelps ME, Huang SC, Hoffman EJ, et al. Tomographic measurement of local cerebral glucose metabolic rate in human with [18F]2-fluoro-2-deoxyglucose. Validation of method. Ann Neurol. 1979;6:371–88.
Sokoloff L, Reivich M, Kennedy C, et al. The [14C]de-oxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916.
Mankoff DA, Muzi M, Krohn KA. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method? Mol Imaging Biol. 2003;5:281–5.
Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3(1):1–7.
Heiss W-D, Herholz K. Brain receptor imaging. J Nucl Med. 2006;47:302–12.
Mintun MA, Raichle ME, Kilbourn MR, et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217–27.
Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5(4):584–90.
Gambhir SS. Quantitative assay development for PET. In: Phelps ME, editor. PET molecular imaging and its biological applications. New York: Springer; 2004.
Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol. 2000;27(7):661–70.
Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl Med Biol. 2003;30:833–44.
Ichise M, Fujita M, Seibyl J, et al. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT. J Nucl Med. 1999;40:1902.
Logan J, Fowler J, Volkow N, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(−)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vallabhajosula, S. (2023). Pharmacokinetics and Modeling. In: Molecular Imaging and Targeted Therapy. Springer, Cham. https://doi.org/10.1007/978-3-031-23205-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-031-23205-3_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23203-9
Online ISBN: 978-3-031-23205-3
eBook Packages: MedicineMedicine (R0)